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Commentary 
What is already known on this topic? 
Improving recovery (ie, sustained symptomatic and functional remission) 
remains a challenge in the treatment of schizophrenia. Evidence suggests that 
the median recovery rate for schizophrenia is 13.5%.1 Improving our 
understanding of predictors of recovery, particularly from first-episode 
psychosis (FEP), could enable better specification of treatment approaches 
relevant to individual presentation and illness stage. The OPUS trial is one of the 
largest prospective cohort studies of individuals receiving treatment for FEP to 
date. Participants were recruited from the community and received either a 
specialised assertive outreach approach for FEP or treatment as usual. 
  
What this paper adds 
·     At 10-year follow-up, 25% of individuals displayed sustained positive and 
negative symptomatic remission, with 14% of the sample achieving full 
functional and symptomatic recovery. These data are broadly consistent with 
existing recovery rates.2 
·     After controlling for associations between predictors, lower levels of negative 
symptoms and younger age predicted recovery at 10-year follow-up. This 
suggests that accurate early identification of psychosis in young adults and 
prompt initiation of treatment, particularly approaches targeting negative 
symptoms, can confer long-term benefits for outcome. 
  
Limitations 
·     Findings are reported for the whole study sample, thus results for individuals 
receiving specialised FEP treatment are combined with those receiving 
treatment as usual. Therefore it is not possible to evaluate whether the type of 
treatment received affected recovery rates. 
·     About 40% of the original study sample was lost to follow-up. This group may 
represent hard-to-engage patients. Effective treatment planning, both when 
patients are stable and in crisis, requires collaboration between patient and 
clinical team; therefore hard-to-engage patients are frequently of concern to 
teams. Our knowledge of this group’s treatment needs remains sparse.  
·     The study was conducted in a public healthcare setting; consequently, results 
may not generalise to other models of healthcare provision. 
  
What next in research 
Further reports of long-term outcomes for prospective FEP cohorts are needed. 
In particular, findings for the contribution of evidence-based interventions - such 
as cognitive behavioural therapy or supported employment programmes - to 
recovery rates would be welcomed. 
  
Do these results change your practices and why? 
The study supports an increasing body of evidence highlighting the continued 
need for early, accurate identification of FEP.3 The trial also emphasises that 
integrative treatment models are needed to improve outcomes for both the 
functional and symptomatic aspects of recovery, incorporating pharmacological 
and psychological interventions alongside interventions that support individuals 
back into education, training or employment. For practitioners working as part 
of specialised multi-professional early intervention teams the observation that 
these factors may be implicated in recovery will not come as a surprise. 
However, for those working in generic mental health teams the findings highlight 
the continued need to look beyond ‘one size fits all’ routine care and crisis 
management in treating psychosis.   
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Prognosis 
  
  
ABSTRACT FROM: Austin SF, Mors O, Secher RG, et al. Predictors of recovery in 
first episode psychosis: the OPUS cohort at 10 year follow-up. Schizophr Res 
2013;150:163-8. 
  
Patients/participants: Participants with first episode psychosis who had a 
diagnosis of schizophrenia spectrum disorder (ICD 10: block F20-29), had not 
received more than 12 weeks of anti-psychotic medication, and were aged 
between 18 and 45 years. People with schizotypal disorder (F21) were excluded 
because they do not experience psychotic symptoms. All participants were 
recruited from the OPUS trial. 
  
Setting: Centres in Denmark (Copenhagen and Aarhus); 1998 to 2000 (baseline) 
  
Prognostic factors: Severity of positive and negative symptoms (Schedules for 
Positive and Negative Symptoms (SAPS/SANS)); course of illness over the past 
two years; level of functioning (Global Assessment of Functioning scale (GAF)); 
pre-morbid functioning (pre-morbid adjustment scale); duration of untreated 
psychosis (Interview for Retrospective Assessment of Onset of Schizophrenia); 
days of hospitalisation; number of contacts with psychiatric services; number of 
days in supported housing. 
  
Control: None 
  
Follow up period: 10 years. Follow up rate at 10 years was 61% (304 of 496). 
  
Outcomes 
Recovery after ten years: 42 of 304 (14%) participants who completed follow 
up met the criteria for full recovery at 10 years (defined as stable remission of 
both negative and positive symptoms, no psychiatric admissions to hospital or 
living in supported accommodation for the past two years, currently engaged in 
work or study and a GAF score of over 60). 
Rates of symptom remission and full recovery: Rates of full recovery appeared 
stable at two, five and 10 years; however, not the same people achieved 
remission or recovery at each follow-up. Overall, 64% participants achieved 
symptom remission at least once, and nearly 30% achieved full recovery at some 
point during the 10 years. 
Predictors of recovery: Baseline predictors accounted for 22% of the variance in 
rates of full recovery. Lower severity of negative symptoms at baseline (odds 
ratio (OR) 0.53, 95% CI 0.36 to 0.78) and earlier age at diagnosis (OR 0.92, 95% 
CI 0.86 to 0.99) were predictive of recovery at 10 years. At one-year follow-up, 
negative symptoms were found to independently predict recovery at 10 years 
(OR 0.49, 95% CI 0.25 to 0.98). 
